Antibody and cytokine mean, standard deviation and median within Ridley Jopling groups and BI groups.

Notes:Kruskal-Wallis non-parametric testing used for all significance testing. Baseline serum was available from all 303 cases in the study. Anticeramide was not assessed for 7 individuals. Differences in markers across three Ridley-Jopling groupings reached statistical significance in five markers.For PGL1_IgG, BT versus BL (pFor PGL1_IgM, BT versus BL (pFor LAM_IgG1, BT versus BL (pFor LAM_IgG3, BT versus BL (pFor S100, BT versus BL (pFor Anticeramide, only negative smear versus 3+ smear approached significance (p = 0.054).